Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Phase 4	2026-07-07		NCT06169371

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Illinois at Chicago	211

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Iowa Holden Comprehensive Cancer Center	Iowa City	United States	1
Ohio State University Comprehensive Cancer Center	Columbus	United States	548
University of Illinois	Chicago	United States	238

Clinical trials